Male Contraceptive Development Program (U01)

 

This Funding Opportunity Announcement (FOA) invites applications for target discovery and validation, lead discovery and optimization, preclinical and/or clinical development of safe and effective male contraceptive products. This program aims to support a wide range of research, both basic and applied, with the goal of developing clinically useful male contraceptive products. There is no safe, effective and reversible male contraceptive drug product in the market. Thus, this program is critical in support of research with the goal of identifying male contraceptive targets and developing products to alleviate this problematic challenge.

Deleted 09/27/2013 (Archived.) RFA-HD-14-023 Agency: Department of Health and Human Services
Office: National Institutes of Health Cooperative Agreement Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. 08/27/2013 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-14-023.html FBOWebmaster@OD.NIH.GOV $1,800,000.00 Awards up to $200,000.00